Chiroscience Group Plc - U.CCC- Profile

Chiroscience Group plc is a pharmaceutical company primarily utilising its diverse technology platform to discover and develop novel medicines for improved healthcare. The group has three main activities: Chiroscience R&D based in Cambridge and Stevenage in England and in Seattle, Washington in the United States of America (discovers and develops innovation small molecule drugs and related diagnostics); Rapigene (creates and provides genomic technologies and services to partner companies and drug discovery programmes) and ChiroTech (provides chiral technology services to customers). Chiral technology services accounted for 73% of fiscal 1999 revenues ; drug discovery and development, 26% and others, 1%.